Tasly Pharmaceutical Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 12.41% vs -4.78% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 429.94% vs -66.07% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,164.80",
          "val2": "1,925.80",
          "chgp": "12.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "452.90",
          "val2": "313.80",
          "chgp": "44.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.30",
          "val2": "5.40",
          "chgp": "-38.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "14.90",
          "val2": "130.70",
          "chgp": "-88.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "364.60",
          "val2": "68.80",
          "chgp": "429.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "209.20%",
          "val2": "101.20%",
          "chgp": "10.80%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -3.17% vs -2.03% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 23.54% vs -15.49% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,150.10",
          "val2": "8,416.60",
          "chgp": "-3.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,824.70",
          "val2": "1,934.80",
          "chgp": "-5.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "34.00",
          "val2": "64.80",
          "chgp": "-47.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "104.30",
          "val2": "-329.70",
          "chgp": "131.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,061.30",
          "val2": "859.10",
          "chgp": "23.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "166.90%",
          "val2": "170.20%",
          "chgp": "-0.33%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

2,164.80

1,925.80

12.41%

Operating Profit (PBDIT) excl Other Income

452.90

313.80

44.33%

Interest

3.30

5.40

-38.89%

Exceptional Items

14.90

130.70

-88.60%

Consolidate Net Profit

364.60

68.80

429.94%

Operating Profit Margin (Excl OI)

209.20%

101.20%

10.80%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 12.41% vs -4.78% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 429.94% vs -66.07% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

8,150.10

8,416.60

-3.17%

Operating Profit (PBDIT) excl Other Income

1,824.70

1,934.80

-5.69%

Interest

34.00

64.80

-47.53%

Exceptional Items

104.30

-329.70

131.63%

Consolidate Net Profit

1,061.30

859.10

23.54%

Operating Profit Margin (Excl OI)

166.90%

170.20%

-0.33%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -3.17% vs -2.03% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 23.54% vs -15.49% in Dec 2024

All Annual Results